We are excited to attend AACR 2025 and share how we are advancing spatial biology and multiomics to uncover new insights in cancer research.
Stop by booth #2320 to see our fit-for-purpose solutions like:
- PaintScape™ Platform: Multiplexed visualization of 3D genome architecture and chromosomal structure in single cells.
- CosMx® SMI: Reveal the entire tissue biology with unbiased, single-cell whole transcriptome coverage.
- nCounter® Analysis System: Unlock rapid, high-confidence gene expression insights—delivered in less than 24 hours.
- CellScape™ Platform: Improvements in data and image quality while decreasing file sizes and processing times with new PowerOMX™.
- GeoMx® DSP: Unparalleled discovery multiomics with GeoMx® WTA and over 1200 proteins.
Exhibitor Spotlight
Expanding the Limits of Biology: Comprehensive Integrated Technologies for Multiomics in Oncology
Join our workshop as we explore the future of multiomics research applications in oncology with Bruker Spatial Biology. Discover our fit-for-purpose solutions, integrating spatial transcriptomics, proteomics, genomics and bulk multiomics to unlock new biological insights. Learn more about our product roadmap and upcoming innovations that expand beyond the limits of discovery and translational oncology research. The session will also feature customer research showcasing how Bruker Spatial Biology’s comprehensive multiomic technologies are transforming oncology research and precision medicine.
Date & Time: Tuesday, April 29 3:00 PM - 4:00 PM CDT
Joseph Beechem,
PhD
Chief Scientific Officer, Bruker Spatial Biology
Oliver Braubach,
PhD
Director of R&D, Bruker Spatial Biology
Jude Dunne,
PhD
VP New Product Development, Bruker Spatial Biology
William Hwang,
MD, PhD
Assistant Professor, Harvard Medical School; Principal
Investigator, Massachusetts General Hospital; Associate Faculty Member, Broad Institute
of MIT and Harvard
Posters
| 2779 | Functional Genomics: Large Scale Approaches to Cancer Gene Discovery | April 28 2pm-5pm | 11 | Whole transcriptome spatial exploration of cultured tumor cells at subcellular resolution: Y. Cui | Bruker Spatial Biology | CosMx |
| 2080 | Spatial Proteomics and Transcriptomics 2 | April 28 2pm-5pm | 32 | Whole Transcriptome Single Cell Spatial Imaging of Tumor vs Normal Tissue Microarray: J. Beechem | Bruker Spatial Biology | CosMx |
| 2067 | Spatial Proteomics and Transcriptomics 2 | April 28 9am-12pm | 32 | Single-cell spatial whole transcriptome reveals tumor heterogeneity and stromal dynamics in invasive ductal carcinoma of the breast: L. Zhang | Bruker Spatial Biology | CosMx |
| 2078 | Spatial Proteomics and Transcriptomics 2 | April 28 9am-12pm | 32 | Single-cell spatial transcriptomics in colon adenocarcinoma reveals tumor heterogeneity and immune microenvironmental shifts: M. Hoang | Bruker Spatial Biology | CosMx |
| 2068 | Spatial Proteomics and Transcriptomics 2 | April 28 9am-12pm | 32 | Mapping the spatial whole transcriptome from normal to tumor tissue in renal clear cell carcinoma: Tumorigenesis and microenvironmental shifts at single-cell resolution: S. He | Bruker Spatial Biology | CosMx |
| 2091 | Spatial Proteomics and Transcriptomics 2 | April 28 9am-12pm | 32 | Integrating single-cell spatial whole transcriptome and histopathology to uncover drivers of tumor heterogeneity in lung adenocarcinoma and squamous cell carcinoma: M. Patrick | Bruker Spatial Biology | CosMx |
| 751 | Spatial Proteomics and Transcriptomics 1 | April 27 2pm-5pm | 32 | High-resolution and AI-enabled single-cell spatial transcriptomics and histopathology integrated to reveal tumor differentiation and immune exclusion in skin squamous cell carcinoma: P. Danaher | Bruker Spatial Biology | CosMx |
| 1880 | Proteomic Signatures in Cancer | April 28 9am-12pm | 26 | Advancing spatial discovery multiomics: Integration of a novel 1000+ plex discovery proteome atlas with an 18,000+ plex whole transcriptome atlas for same-slide investigation multiple cancer pathologies: A. Heck | Bruker Spatial Biology | CosMx |
| 177 | Where's Waldo: Spatial Complexity of the Tumor Microenvironment 1 | April 27 2pm-5pm | 7 | Increasing throughput of high-quality spatial biology data via low magnification, high NA scanning on the CellScape platform: J.Schwarz | Bruker Spatial Biology | CellScape |
| 2084 | Spatial Proteomics and Transcriptomics 2 | April 28 9am-12pm | 32 | Development of a novel tri-omic spatial biology assay that provides in-depth immune profiling of the tumor immune microenvironment: A. Christians | Bruker Spatial Biology | CellScape |
| 6483 | Multi-omics and the Predictive Power of the Tumor Microenvironment | April 30 9am-12pm | 2 | Powerful end-to-end spatial analyses using precise spatial proteomics: C. Jackson | Bruker Spatial Biology | CellScape |
| 5750 | Revolutionizing Cancer Care Through Inclusive Clinical Research | April 30 9am-12pm | 30 | Comprehensive spatial profiling of the tumor immune microenvironment in triple negative breast cancer from Black women: F. Dezem, A. Christians, O. Braubach, J. Plummer | St. Jude Children's Research Hospital, Bruker Spatial Biology | CellScape |
| 2746 | Epigenetic Mechanisms of Cancer Resistance and Progression | April 28 2pm-5pm | 10 | 3D genome structural alterations in biological pathway genes drive the progression of cells from normal epithelium to metastatic cancer: H. Nguyen | Bruker Spatial Biology | PaintScape |
| 2852 | Origins and Mechanisms of Genomic Instability | April 29 9am-12pm | 14 | Mapping single cell spatial 3D genome landscape of localized and metastatic breast cancer sub-types: S. Chattoraj | Bruker Spatial Biology | PaintScape |
| 5073 | Single Cell and Spatial Molecular Analysis | April 29 9am-12pm | 47 | Whole transcriptome spatial molecular imaging in matched pre and post treatment specimens to identify treatment-associated effects in pancreatic adenocarcinoma: B. Aswathi | Massachusetts General Hospital | CosMx |
| 6466 | Multi-omics and the Predictive Power of the Tumor Microenvironment | April 30 9am-12pm | 2 | Discovery Proteome and Whole Transcriptome Atlas analysis of skin cancer reveals biomarkers associated with immunotherapy response and resistance: A. Kulasinghe | Frazer Institute, The University of Queensland | GeoMx |
| 5929 | Uncovering How Secreted Factors Sculpt the Tumor Microenvironment | April 28 9am-12pm | 7 | Development of a multi-omic spatial phenotyping assay for affirmative detection of CAR-T cells in the tumor immune microenvironment of solid pediatric tumors J.Plummer, F. Segato-Dezem, Y. Liu, A. Wani, H. Chasteen, A. Christians, J. Boog, R. Chen, H. Choi, A. Acharya, O. Braubach, G. Krenciute, J. Chiang, C. De Renzo, K. Bertrand | St. Jude Children's Research Hospital, Bruker Spatial Biology | CellScape |
Meet with Bruker Spatial Biology
Interested in seeing how our solutions can elevate your research? Let’s meet at AACR! Contact us today to schedule a one-on-one meeting or learn more about our technologies.